According to Tenet Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 28.1354. At the end of 2022 the company had a P/E ratio of 12.7.
Year | P/E ratio | Change |
---|---|---|
2022 | 12.7 | 32.67% |
2021 | 9.58 | -9.1% |
2020 | 10.5 | -155.96% |
2019 | -18.8 | -212.04% |
2018 | 16.8 | -874.8% |
2017 | -2.17 | -71.79% |
2016 | -7.69 | -64.47% |
2015 | -21.6 | -104.7% |
2014 | 461 | -1532.65% |
2013 | -32.2 | -232.69% |
2012 | 24.2 | -44.5% |
2011 | 43.7 | 1401% |
2010 | 2.91 | -78.95% |
2009 | 13.8 | -27.89% |
2008 | 19.2 | -167.91% |
2007 | -28.2 | 592.4% |
2006 | -4.08 | -18.59% |
2005 | -5.01 | 174.04% |
2004 | -1.83 | -72.68% |
2003 | -6.69 | -199.5% |
2002 | 6.72 | -80.31% |
2001 | 34.1 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
1.63 | -94.22% | ๐บ๐ธ USA | |
19.2 | -31.66% | ๐บ๐ธ USA | |
14.9 | -47.12% | ๐บ๐ธ USA | |
11.5 | -59.10% | ๐บ๐ธ USA | |
30.0 | 6.56% | ๐บ๐ธ USA | |
11.0 | -60.91% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.